AC Immune SA (NASDAQ: ACIU) Has Succeeded To Excite In 2024, The Stock Is Down -52.80% Year-To-Date

AC Immune SA (NASDAQ:ACIU)’s traded shares stood at 0.32 million during the last session, with the company’s beta value hitting 1.06. At the close of trading, the stock’s price was $2.36, to imply a decrease of -0.84% or -$0.02 in intraday trading. The ACIU share’s 52-week high remains $5.14, putting it -117.8% down since that peak but still an impressive 24.58% since price per share fell to its 52-week low of $1.78. The company has a valuation of $234.11M, with an average of 172.75K shares over the past 3 months.

AC Immune SA (NASDAQ:ACIU) trade information

After registering a -0.84% downside in the last session, AC Immune SA (ACIU) has traded red over the past five days. The stock hit a weekly high of 2.80, dropping -0.84% in its intraday price action. The 5-day price performance for the stock is -13.87%, and -27.50% over 30 days. With these gigs, the year-to-date price performance is -52.80%.

AC Immune SA (ACIU) estimates and forecasts

Looking at statistics comparing AC Immune SA share performance against respective industry, we note that the company has underperformed competitors. AC Immune SA (ACIU) shares are -15.41% down over the last 6 months, with its year-to-date growth rate lower than industry average at -9.86% against 13.30%. The rating firms project that company’s revenue will shrink -42.70% compared to the previous financial year.

Revenue forecast for the current quarter as set by 3 analysts is $6.03 million. Meanwhile, for the quarter ending Jun 2024, a total of 2 analyst(s) estimate revenue growth to $550k.Earnings reports from the last fiscal year show that sales brought in -$ and $1.84 million respectively in the corresponding quarters.

ACIU Dividends

AC Immune SA has its next earnings report out in May. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. AC Immune SA has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.